News PharmAla Biotech receives $50K grant for AI drug discovery The grant will bolster PharmAla's use of in-silico modelling Natalia Buendia CalvilloJune 9, 2023
News Apex Labs U.S.-based supplier of psilocybin approved by Health Canada The company has a specific focus on Veteran patients Natalia Buendia CalvilloJune 9, 2023
News Lucy Scientific Discovery sends acquisition proposal to Pasithea Therapeutics Lucy's offer of $0.85 per share represents a 142 per cent premium on Pasithea's share price Natalia Buendia CalvilloJune 5, 2023
News Algernon Pharmaceuticals completes final dosing in DMT study for stroke and TBI treatment AGN Neuro plans to publish the data from the study in an upcoming issue of a peer-reviewed paper Natalia Buendia CalvilloJune 5, 2023
Psychedelics Kentucky to invest US$42M in psychedelics research for opioid use disorders The money will come from the state's opioid settlement funds and the research will focus on ibogaine Rowan DunneJune 5, 2023
News Reunion Neuroscience to be acquired by MPM BioImpact in US$13.1M deal The deal is expected to close in the third quarter Natalia Buendia CalvilloJune 1, 2023
Psychedelics Beckley Waves establishes ethics council for the psychedelics sector Beckley Waves was created by the Beckley Foundation's Founder Amanda Feilding Rowan DunneJune 1, 2023
News Colorado governor signs bill regulating psychedelics The Natural Medicine Health act will take effect on July 1 Natalia Buendia CalvilloMay 26, 2023
Psychedelics European Parliament launches medical psychedelics action group The group aims to foster EU-funded research on psychedelics and promote drug policies based on scientific evidence Rowan DunneMay 25, 2023
Psychedelics MindBio Therapeutics receives approval for LSD study for major depression The study has been approved by the Clinical Trials Registry Rowan DunneMay 24, 2023